Monday, February 18, 2013

• Roche and Chiasma announce collaboration to develop and commercialize Chiasma's Octreolin® for acromegaly and neuroendocrine tumorsPR Newswire (Mon, Feb 18)

Sunday, February 17, 2013

• AbbVie suspends Leukemia therapy trials. Bloomberg reportstheflyonthewall.com (Sun, Feb 17)

Friday, February 15, 2013

• Roche's Worth $58 On Continued Growth And Strong Pipelineat Forbes (Fri, Feb 15)
• Revenues Rise at IncyteZacks (Fri, Feb 15)

Wednesday, February 13, 2013

• Roche Collaborates with RQx PharmaZacks (Wed, Feb 13)

Tuesday, February 12, 2013

• RQx Pharmaceuticals and Genentech Enter Drug Discovery Collaboration to Develop Novel Drug CompoundsPR Newswire (Tue, Feb 12)

Monday, February 11, 2013

• Affymetrix Links Up with DNA LinkZacks (Mon, Feb 11)

Friday, February 8, 2013

• Loss Widens at Alnylam, Sales FallZacks (Fri, Feb 8)

Tuesday, February 5, 2013

• Allergan Reports Mixed Q4, But Bullish Margin Outlookat Investor's Business Daily (Tue, Feb 5)
• ROCHE HOLDING LTD /FI FinancialsEDGAR Online Financials (Tue, Feb 5)

Friday, February 1, 2013

• Roche Grows in 2012Zacks (Fri, Feb 1)
• Merck Beats, Issues OutlookZacks (Fri, Feb 1)
• [video] Roche's CEO on Profit Pipelineat CNBC (Fri, Feb 1)

Thursday, January 31, 2013

• Pipeline Progress at EndocyteZacks (Thu, Jan 31)
• Obinutuzumab (GA101) Significantly Improved Progression-Free Survival in People With Chronic Lymphocytic Leukemia (CLL)Business Wire (Thu, Jan 31)

Wednesday, January 30, 2013

• Why Analysts Are Dead Wrong On Immunogenat Seeking Alpha (Wed, Jan 30)
• Roche Teams Up With AfraxisZacks (Wed, Jan 30)
• Cancer drugs give Roche a 2012 profit boostAP (Wed, Jan 30)
• Roche posts modest profit gain for 2012AP (Wed, Jan 30)

Monday, January 28, 2013

• Wider Loss at ImmunoGenZacks (Mon, Jan 28)

Friday, January 25, 2013

• Biogen, Illumina Ready Q4 Reports As Stocks Struggleat Investor's Business Daily (Fri, Jan 25)
• The Zacks Analyst Blog Highlights: Roche, Aetna, WellCare Health Plans, Coventry Health Care and HumanaZacks (Fri, Jan 25)

Thursday, January 24, 2013

• Label Expansion for Roche's AvastinZacks (Thu, Jan 24)

Wednesday, January 23, 2013

• FDA Approves New Use of Avastin Plus Chemotherapy for People with Metastatic Colorectal CancerBusiness Wire (Wed, Jan 23)

Friday, January 18, 2013

• Pipeline Advances at ExelixisZacks (Fri, Jan 18)

Add RHHBY News to My Yahoo!